ABSTRACT. High levels of plasma erythropoiesis stimulating factor(s) (ESF) have been found in neonatal WLOmice during rapid growth. A previous study on hypertransfused neonatal animals indicated that the high ESF could not be due to the concomitant postnatal anemia alone. The present investigation was performed to answer the question: Is the high plasma ESF in neonatal WLO-mice erythropoietin (Ep) alone, or Ep in combination with other factors? The ESF of plasma from 20-day-old animals and standard Ep were compared in a cell culture assay for ESF based on erythroid colony formation, and also by means of gel filtration chromatography and affinity chromatography. Nonfractionated plasma and standard Ep showed parallel dose response curves and additive activity in the ESF assay. After gel filtration the detectable ESF of plasma was eluted in the same position as that of standard Ep, corresponding to an estimated molecular weight range of 34-65000 daltons. The ESF of intact plasma, fractionated plasma, and standard Ep were identically bound to and eluted from the affinity chromatography column. These results show that the ESF of plasma from 20-day-old animals can neither be separated into several factors, nor distinguished from that of standard Ep by the methods used. It is therefore concluded that the high plasma ESF found in neonatal WLOmice probably consists of Ep alone. (Pediatr Res 21: 148-151,1987) Abbreviations CFU,,:, erythroid colony forming cell Ep, erythropoietin ESF, erythropoiesis stimulating factor(s) MW, molecular weight PBS, phosphate-buffered saline S-200 column, Sephacryl S-200 superfine column WG-column, wheat germ lectin-Sepharose 6MB column V,, void volume IGF-I, insulin-like growth factor I Erythropoiesis in the adult mammal is regulated mainly through Ep in response to tissue hypoxia, although non-Ep factors may be involved (1). Erythroid progenitor cells in culture are also sensitive to these factors. Thus, cell culture assays for Ep based on erythroid colony formation determine ESF, which is the net activity of Ep and other erythropoietic stimulatory factors and possible inhibitory factors present in the samples.
High levels of plasma ESF have been found in neonatal WLOmice during rapid growth with only a moderate concomitant postnatal anemia. The highest levels were found at about 20 days of age (2) . Hypertransfusion reduced but did not totally suppress the ESF in 20-day-old animals (3) . This indicated that the high levels found were not due to the anemia alone, and supported other studies indicating that regulation of erythropoiesis in the neonate differs from the adult.
Based on these findings (2, 3) , the present investigation was performed to answer the question: Is the high plasma ESF found in neonatal WLO-mice Ep alone or Ep in combination with other factors? To accomplish this the ESF of plasma from 20-day-old animals and standard Ep were compared in a cell culture assay and also by means of gel filtration chromatography and affinity chromatography.
MATERIALS AND METHODS
WLO-mice (4) of both sexes were sacrificed when 20 days old. The litter size was between five to 10 pups. Blood was collected in heparinized tubes (Caraway, American Dade, Division of American Hospital Supply Corporation, Miami, FL). The tubes were immediately centrifuged, and the plasma from each litter pooled and stored at -70" C. Plasma from several litters were pooled to achieve enough material for the various experiments. The plasma batches to be used for dose response studies in the ESF assay were dialysed for 3 days against distilled water (5). Precipitates were removed by centrifugation and the supernatants used in the assay. Undialysed plasma was used for the chromatography studies, and none of the chromatography fractions was dialysed before being assayed for ESF.
Sheep plasma erythropoietin (step 111, Connaught Laboratories, Ontario, Canada) served as standard Ep. The lyophilized step 111 preparation was dissolved in a-medium (Flow Laboratories, Herts, U.K.) and stored at -70" C.
ESF was determined by a modification of the cell culture assay described by Higi and Falkanger (6), using hepatic CFUES from newborn WLO-mice (5) . The test samples were added at a concentration of 100 pl/ml, except for the dose response studies. a-medium was added to a final volume of 250 p1 per culture well. The number of erythroid colonies formed is proportional to the ESF present in the cultures in a log-dose fashion. The results were normalized to adjust for interassay variations (5) .
Two dose response studies were carried out with the ESF assay. First, plasma from 20-day-old mice and standard Ep were tested separately in concentrations from 6.25 to 200 pl/ml and 6.25 to 200 mU/ml, respectively. This was done to test parallelity of the two dose response curves. Second, the combined activity of plasma and standard Ep was studied. A fixed amount of plasma (100 pl/ml) was added to the cultures along with increasing concentrations of standard Ep (6.25-200 mU/ml). Parallel cultures with standard Ep alone were done in the same experiment. MW estimations were done by gel filtration chromatography at 4" C on a S-200 column (Pharmacia Fine Chemicals AB, Uppsala, Sweden). The column dimensions were 74 by 1.5 cm, i.e. 130.8 ml bed volume. The gel was equilibrated and the elutions carried out with PBS, pH 7.4. Flow was adjusted to 12 ml/h and 1.2 ml fractions were collected. The void volume (V,) was 45.6 ml. The samples applied were 2.5 ml of plasma and standard Ep (625 mu), respectively. Each fraction was assayed for ESF. Protein standards and Blue Dextran 2000 (Gel Filtration Calibration Kit, Pharmacia Fine Chemicals AB) were dissolved in PBS. The plasma fractions that showed activity in the ESF assay were studied by affinity chromatography.
Affinity chromatography was carried out at 4" C on a WGcolumn (Pharmacia Fine Chemicals AB). This column selectively binds glycoproteins containing certain sugar residues. A modification of the method of Spivak et al. was employed (7, 8) . The column dimensions were 4.7 by 0.7 cm, i.e. 1.8 ml bed volume. The gel was equilibrated with PBS, pH 7.4. Flow was adjusted to 12 ml/h and 1 ml fractions were collected. Following application of the sample, 0.9 ml, the column was washed with PBS until the effluent was free of protein. Thereafter 1.8 ml of a 1 x M solution of NIN1-diacetylchitobiose (Sigma Chemical Company, St. Louis, MO) in PBS was applied. When the elution sugar had entered the gel bed flow was stopped and the column warmed by hand for 10 min. Elution was then reassumed with PBS until the eluate was free of protein. The samples applied were 0.9 ml of plasma, plasma fractions from the S-200 column that had shown activity in the ESF assay (fractions 55, 57-62, 63-64) and standard Ep (225 mu). The S-200 column plasma fractions 57-62 and 63-64 had been pooled before studied by affinity chromatography, respectively. Each WG-column fraction was assayed for ESF. The gel was regenerated with 18 ml of 1 x 10-I M Tris/HCl buffer containing 5 X lo-' M NaCl, pH 8.5, and 18 ml sodium acetate buffer containing 5 x lo-' M NaCl, pH 4.5. The gel was then reequilibrated with PBS, pH 7.4.
A peristaltic pump (P-I, Pharmacia Fine Chemicals AB) and a fraction collector (Ultrorack 7000, LKB, Bromma, Sweden) were used for all the chromatographies. Protein contents of column effluents were continuously measured sphectrophotometrically at 280 nm (Uvicord 8003, LKB). All fractions were stored at -30" C before being assayed for ESF. Column effluents free of protein and nonfractionated aliquots of the actual samples served as additional controls in these ESF assays.
The level of significance of differences between means were determined by Student's 1 test.
RESULTS
In the first dose response study 25 pl/ml of plasma showed the same ESF activity as 6.25 mU/ml standard Ep ( p > 0.5), and 100 pl/ml of plasma equalled that of 25 mU/ml Ep ( p > 0.5) (Fig. 1) . Within this range the ESF response was proportional to the log of the dose of plasma or standard Ep added, with no difference in slope. Thus, within the given range of activity the two dose response curves were parallel. Plasma in a concentration of 200 pl/ml showed no activity in the ESF assay and was even inhibitory as compared to nonstimulated control cultures ( p < 0.01). This may reflect that plasma contained inhibitory factors and/or had replaced too much of the nutritional factors present in a-medium.
Compared to plasma alone, the observed ESF response increased when increasing doses of standard Ep were added to the cultures along with the fixed amount of plasma (100 pl/ml) (Fig.  2) . The highest combined response was found at a standard Ep concentration of 100 mU/ml ( p < 0.02). However, the maximal combined effect on erythroid colony formation equalled that observed when the culture system was maximally stimulated by standard Ep alone (p > 0.05). Thus, the effect of combining plasma and standard Ep was neither synergistic nor inhibitory, but truly additive in the present ESF assay.
The plasma fractions 57-62 from the S-200 column, corresponding to an estimated MW of 39-55000 daltons, showed high ESF levels as compared to column effluent free of protein ( p < 0.001) (Fig. 3) . Much lower levels were found in the plasma (Fig. 4) . Data from the pooled plasma fractions 63-64 are not shown on Figure 4 . The nonfractionated aliquot of this sample did not show activity in the ESF assay ( p > 0.05), nor was there any ESF to be found in the nonretarded fractions from the WG-column ( p > 0.05). Nevertheless, the fractions number 10 and 13 following application of the elution sugar showed a low ESF level ( p < 0.05).
The S-200 and WG-column effluents free of protein did not have any inhibitory or stimulatory effect in the ESF assay as compared to control cultures with no sample or standard Ep added ( p > 0.4), nor did they change the activity of 50 mU/ml standard Ep ( p > 0.5).
DISCUSSION
Several non-Ep humoral factors stimulate erythropoiesis in vivo, but their possible physiological role in the regulation of erythropoiesis remains unclear. Cell culture assays for Ep are also sensitive to such factors (1, [8] [9] [10] [11] [12] [13] . The observed effect varies with the culture system used, indicating that these factors may influence erythropoiesis in different ways and at various stages of differentiation (8, 14) . Plasma from 20-day-old WLO-mice and standard Ep showed parallel dose response curves and additive activity in the cell culture assay for ESF based on erythroid colony formation (Figs.  1 and 2) . These results indicate that the ESF in neonatal mouse plasma and standard Ep, respectively, have the same final effect on the target cell, the CFUE. However, they do not prove that the effector mechanism(s) is identical.
After gel filtration most of the detectable ESF of plasma was eluted in the same position as that of standard Ep (Fig. 3) . This shows that at least a significant part of the high plasma ESF is the result of one or more factors with a MW within the same range as Ep. IGF-I is a possible non-Ep factor. This somatomedin in physiological concentration stimulates the growth of murine CFUES in vitro (12) . The somatomedins all have MWs of 6-10000 daltons. However, in the human serum they are bound to carrier proteins, and some of the circulating IGF-I has been shown to have a MW of about 38000 + 7000 daltons at neutral pH (15) . This is probably also the case in the mouse (16) .
A plasma volume of 2.5 ml was applied to the S-200 column, but the detectable ESF was eluted in a total volume of 10.8 ml (nine fractions). Thus, the ESF of plasma was necessarily diluted by the gel filtration procedure. Having this in mind, the plasma fractions 57-61 showed approximately three times higher ESF levels than expected as compared to nonfractionated plasma (Fig. 3) . Together with the observation that some plasma fractions were inhibitory in the ESF assay, this probably reflects that the S-200 column had separated some inhibitory factor(s) from the stimulatory activity. However, the data do not exclude the possibility that erythropoietic stimulatory factors of other MWs are present but not detected, because they are too much diluted and/or eluted along with inhibitory activity. Affinity chromatography performed as described in "Materials and methods" is an accepted method to separate Ep from other non-Ep erythropoietic stimulatory factors (7, 8, 17) . In the present study the ESF of intact plasma and the ESF of plasma fractions from S-200 column were bound to and eluted from the WG-column as that of standard Ep (Fig. 4) . This shows that a significant part of the plasma ESF is due to one or more glycoproteins containing at least one of the same sugar residues as Ep. Samples of 0.9 ml were applied to the WG-column, but the detectable ESF was eluted in volumes varying from 1 to 7 ml. Therefore, the affinity chromatography procedure must also have diluted the ESF of the samples. However, some fractions showed remarkably high ESF levels as compared to the intact samples (Fig. 4) . The WG-column fractions 8-10 of intact plasma showed approximately 10 times higher levels and those of the S-200 plasma fractions 57-62 were about seven times more active in the ESF assay than expected. It should be noted that all these fractions showed higher ESF levels than the intact samples. Even fractions 8-9 of standard Ep showed approximately four times higher ESF levels than one would expect from the dilution. This indicates that the WG-column had separated some inhibitory factor(s) from the stimulatory activity, both in plasma and standard Ep. Again, it is still possible that other erythropoietic stimulatory factors are not detected because they are too much diluted and/or eluted along with inhibitory activity.
The presented data show that the plasma ESF in 20-day-old WLO-mice cannot be separated into several factors by the methods used. Furthermore, the plasma ESF showed the same final biological activity on the C W E , was found within the same MW range and had at least one of the same sugar residues as the ESF of standard Ep. It is therefore concluded that the high plasma ESF found in neonatal WLO-mice, as represented by 20-day-old animals, probably consists of Ep alone.
The physiological stimulus behind the high Ep production is not known. The expansion of the blood volume and the consequent need for red blood cell production is high in the neonatal period. Also, the Ep sensitivity of the red cell progenitor, the C W E , decreases, reaching adult levels between day 8 and 20 (1 8, 19 ). This could explain the high plasma ESF levels found around day 20 and also that ESF have been shown to increase further after hematocrit started to rise (2) . However, a previous study on hypertransfused mice indicated that the high plasma ESF in 20-day-old animals could not be due to the moderate concomitant postnatal anemia alone (3). In addition, Meberg el al. (2) showed that plasma ESF remained high until growth ceased between day 40 and 50, despite the hematocrit reaching adult levels beforehand. In accordance with their hypothesis, it is possible that factors related to the rapid growth could stimulate Ep production.
